-
A Manifestation of Strength ▏ACCB once again passed the international exte...
Recently, the National Center for Clinical Laboratories (NCCL) published the results of the 2019 International External Quality Assessment of Circulating Tumor DNA (ctDNA) Gene Mutation Detection, Jiaxing ACCB Diagnostics Ltd. (hereinafter referred to as Jiaxing ACCB), a wholly-owned subsidiary of Beijing ACCB Bio...MORESource：Time：2020-02-19Click：2076 -
ACCB Won 2018 “Beijing Science and Technology Awards”According to the Measures of Beijing Municipality for Science and Technology Awards, through the review by the Municipal Science and Technology Awards Review Committee and the approval by the municipal government, ACCB’s project “development and application of gene companion diagnostic technology products for lung cancer and colo...MORESource：Time：2020-02-19Click：1480 -
Official Announcement | ACCB’s Integration with the Emerging Company in Liqu...Precise treatment for tumors is one of the most cutting-edge fields of precision medicine. In the past year, we have witnessed the emergence of new achievements, new technologies and new products in such popular fields as immunotherapy and liquid biopsy, and experienced successive failures of clinical trials for new drugs based on new targets...MORESource：Time：2020-02-19Click：1605 -
Good news! ACCB was listed in “Future Medical VB 100”!
With the brand influence that has been fostered through many years of efforts in the field of personalized medicine for cancer and the innovative integration practice by continuously seeking innovation and changes, ACCB surpassed more than one thousand medical enterprises and was successfully listed in the “2018 Future Medical VB 100”.MORESource：Time：2020-02-19Click：1554 -
XU Junpu, CEO of ACCB: Implement the “Belt and Road” Initiative by Means ...Precision medicine has become a common topic in the world. With the advancement of gene sequencing technology and the proposing of the “Belt and Road” initiative, precision medicine has brought benefits to a number of countries and people along the Belt and Road, and many domestic gene sequencing companies have begun to shift their attenti...MORESource：Time：2020-02-19Click：1632